Last reviewed · How we verify
Epidural Morphine
At a glance
| Generic name | Epidural Morphine |
|---|---|
| Also known as | DepoDur, EREM |
| Sponsor | Columbia University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery (PHASE3)
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
- Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia (PHASE4)
- Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epidural Morphine CI brief — competitive landscape report
- Epidural Morphine updates RSS · CI watch RSS
- Columbia University portfolio CI